Laboratoires Pierre Fabre SA - Strategic SWOT Analysis Review

Laboratoires Pierre Fabre SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.

This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope

• Business description - A detailed description of the company’s operations and business divisions.
• Corporate strategy - The analyst’s summarization of the company’s business strategy.
• SWOT analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
• Company history - Progression of key events associated with the company.
• Major products and services - A list of major products, services and brands of the company.
• Key competitors - A list of key competitors to the company.
• Key employees - A list of the key executives of the company.
• Executive biographies - A brief summary of the executives’ employment history.
• Key operational heads - A list of personnel heading key departments/functions.
• Important locations and subsidiaries - A list of key locations and subsidiaries of the company, including contact details.

Highlights

Laboratoires Pierre Fabre SA (Pierre Fabre), a subsidiary of Pierre Fabre Foundation, is a pharmaceutical company, which develops and distributes complementary products, over-the-counter drugs, prescription drugs, natural and consumer health care products, and dermo-cosmetics. The company provides treatment for oncology, dermatology, rare diseases, chronic diseases, smoking cessation, consumer healthcare, natural health, oral health. Pierre Fabre offers its products to customers through healthcare professionals and a network of pharmacies and drugstores under the brands Eau Thermale Avene, Ducray, Klorane, A-Derma, Rene Furterer, Darrow, Dexeryl, among others. It operates in various countries globally including China, Germany, Spain, Italy, the US, Mexico, Brazil, and Poland, among others. Pierre Fabre is headquartered in Paris, Ile-de-France, France.

Laboratoires Pierre Fabre SA Key Recent Developments

• Oct 31, 2024: Press release Fernando Junoy appointed Pierre Fabre Laboratories’ International Managing Director 31 October 2024
• Feb 23, 2024: Pierre Fabre Laboratories, Committed to Combating Rare Pediatric Diseases via Innovative Therapies
• Jan 23, 2024: Eau Thermale Avène Hits a Billion Euros in Turnover, and Strengthens Its Medical Positioning
• Jan 10, 2024: Hervé Hoppenot, Incyte CEO, is appointed on the Board of Pierre Fabre Laboratories 10 January 2024

Reasons to Buy

• Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
• Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
• Understand and respond to your competitors’ business structure and strategies with the analyst’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
• Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.

Note: Some sections may be missing if data is unavailable for the company.